Obesity is associated with impaired responsiveness to once‐daily low‐dose aspirin and in vivo platelet activation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity is associated with impaired responsiveness to once‐daily low‐dose aspirin and in vivo platelet activation
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-01
DOI
10.1111/jth.14445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
- (2018) Mohamad Shebley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
- (2018) Bianca Rocca et al. EUROPEAN HEART JOURNAL
- Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
- (2018) Cornelis Smit et al. Expert Opinion on Drug Metabolism & Toxicology
- Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
- (2018) Peter M Rothwell et al. LANCET
- The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
- (2018) Valerio De Stefano et al. Blood Cancer Journal
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Severe obesity and bariatric surgery alter the platelet mRNA profile
- (2018) Sean P. Heffron et al. PLATELETS
- Type 2 Diabetes, Obesity, and Aspirin Responsiveness ∗
- (2017) Carlo Patrono et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Understanding and applying pharmacometric modelling and simulation in clinical practice and research
- (2016) Joseph F. Standing BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Comparisons between perivascular adipose tissue and the endothelium in their modulation of vascular tone
- (2016) K E Zaborska et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study
- (2016) Lieke Mitrov-Winkelmolen et al. OBESITY SURGERY
- Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge andin vivourinary thromboxane production in healthy male subjects
- (2016) Simona Simeoni et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- The Impact of Obesity on the Pharmacology of Medications Used for Cardiovascular Risk Factor Control
- (2015) Sowndramalingam Sankaralingam et al. CANADIAN JOURNAL OF CARDIOLOGY
- In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
- (2015) Francesco Zaccardi et al. DIABETES
- Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies
- (2015) Prasenjit Manna et al. Metabolic Syndrome and Related Disorders
- Obesity and Cardiovascular Diseases
- (2014) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action
- (2014) P. Patrignani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia
- (2014) Isabella Squellerio et al. THROMBOSIS AND HAEMOSTASIS
- Are Metabolically Healthy Overweight and Obesity Benign Conditions?
- (2013) Caroline K. Kramer et al. ANNALS OF INTERNAL MEDICINE
- Stability of Urinary Thromboxane A2 Metabolites and Adaptation of the Extraction Method to Small Urine Volume
- (2013) Francesca Pagliaccia et al. Clinical Laboratory
- In-Hospital Outcomes of Percutaneous Coronary Interventions in Extremely Obese and Normal-Weight Patients
- (2013) Saeed Payvar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Soluble CD40 Ligand in Morbidly Obese Patients
- (2013) Juan A. Baena-Fustegueras et al. JAMA Surgery
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
- (2012) B. ROCCA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of Body Weight and Extreme Obesity on the Presentation, Treatment, and In-Hospital Outcomes of 50,149 Patients With ST-Segment Elevation Myocardial Infarction
- (2011) Sandeep R. Das et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats
- (2011) N.S. Lobato et al. LIFE SCIENCES
- The role of weight and enteric coating on aspirin response in cardiovascular patients
- (2010) A. PEACE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays
- (2009) Francesca Santilli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now